- Section 1 - About the Company
- Novavax Inc - Key Facts
- Novavax Inc - Key Employees
- Novavax Inc - Key Employee Biographies
- Novavax Inc - Major Products and Services
- Novavax Inc - History
- Novavax Inc - Company Statement
- Novavax Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Joint Venture
- Section 2 – Company Analysis
- Company Overview
- Novavax Inc - Business Description
- Other Break-up: Grants
- Performance
- Other Break-up: Product Sales
- Performance
- Other Break-up: Royalties and Other
- Performance
- R&D Overview
- Novavax Inc - Corporate Strategy
- Novavax Inc - SWOT Analysis
- SWOT Analysis - Overview
- Novavax Inc - Strengths
- Novavax Inc - Weaknesses
- Novavax Inc - Opportunities
- Novavax Inc - Threats
- Novavax Inc - Key Competitors
- Section 3 – Company Financial Ratios
- Financial Ratios - Capital Market Ratios
- Financial Ratios - Annual Ratios
- Performance Chart
- Financial Performance
- Financial Ratios - Interim Ratios
- Financial Ratios - Ratio Charts
- Section 4 – Company’s Lifesciences Financial Deals and Alliances
- Novavax Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
- Novavax Inc, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
- Novavax Inc, Recent Deals Summary
- Section 5 – Company’s Recent Developments
- Sep 25, 2024: Novavax Names Dr. Ruxandra Draghia-Akli as New Executive Vice President and Head of ...
- Feb 29, 2024: Novavax to Participate in TD Cowen's 44th Annual Health Care Conference
- Feb 28, 2024: Novavax Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
- Jan 31, 2024: Novavax Continues Transformation of Company Focused on Product Delivery, Financial Performance and Expanded Portfolio
- Jan 03, 2024: Novavax to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
- Oct 11, 2023: Novavax Advances Science Supporting Protein-based Vaccine Technology at IDWeek 2023 and World Vaccine Congress Europe 2023
- May 09, 2023: Novavax reports Q1 2023 financial results and operational highlights
- May 02, 2023: Novavax to host conference call to discuss first quarter 2023 financial results and operational highlights on may 9, 2023
- Apr 04, 2023: Novavax Grows presence at World Vaccine Congress 2023 and 33rd European Congress of Clinical Microbiology & Infectious Diseases
- Feb 28, 2023: Novavax Reports Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights
- Section 6 – Appendix
- Methodology
- Ratio Definitions
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Novavax Inc, Key Facts
- Novavax Inc, Key Employees
- Novavax Inc, Key Employee Biographies
- Novavax Inc, Major Products and Services
- Novavax Inc, History
- Novavax Inc, Subsidiaries
- Novavax Inc, Joint Venture
- Novavax Inc, Key Competitors
- Novavax Inc, Ratios based on current share price
- Novavax Inc, Annual Ratios
- Novavax Inc, Annual Ratios (Cont...1)
- Novavax Inc, Annual Ratios (Cont...2)
- Novavax Inc, Interim Ratios
- Novavax Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
- Novavax Inc, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
- Novavax Inc, Recent Deals Summary
- Currency Codes
- Capital Market Ratios
- Equity Ratios
- Profitability Ratios
- Cost Ratios
- Liquidity Ratios
- Leverage Ratios
- Efficiency Ratios
- List of Figures
- Novavax Inc, Performance Chart (2019 - 2023)
- Novavax Inc, Ratio Charts
- Novavax Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
- Novavax Inc, Pharmaceuticals & Healthcare, Deals by Type, 2018 to YTD 2024
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook